Ticker

Integrated Service Program Growth Drives Revenue Expansion and Margin Improvement Delivering Improved Profitability and Debt Reduction in Fiscal 2025 Operational Momentum and Balance Sheet Restructuring Position Company for 2026 Growth West Palm Beach, FL, March 31, 2026 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a digital health infrastructure company focused on enabling independent primary…

QHSLab, Inc. (OTCMKTS:USAQ - Get Free Report) rose 15.3% on Tuesday. The stock traded as high as $0.7524 and last traded at $0.7242. Approximately 2,346 shares were traded during mid-day trading, a decline of 46% from the average daily volume of 4,315 shares. The stock had previously closed at $0.6279. QHSLab Trading Up 15.3%

STERIS (NYSE: STE - Get Free Report) and QHSLab (OTCMKTS:USAQ - Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, dividends, analyst recommendations, profitability and earnings. Valuation and Earnings This table compares STERIS and QHSLab"s gross

Revenue increased 25% year over year, gross margins expanded to approximately 67%, and convertible debt was substantially eliminated Improved profitability and early Q-Cog reimbursement activity position the Company for continued platform expansion in 2026 West Palm Beach, FL, Jan. 26, 2026 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ), a digital health infrastructure company supporting primary care…